Search research articles
Contact Us
Filters
Showing results (171-180 of 181) with videos related to
Page
of 19
Sort By:
Thrombosis Research
|
January 1, 1982
Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgery
J J Belch, D R Meek, G D Lowe, et al.
British Journal of Clinical Pharmacology
|
January 1, 1983
Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial
J J Belch, J Cormie, P Newman, et al.
Annals of the Rheumatic Diseases
|
March 1, 1995
Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study
J J Belch, H A Capell, E D Cooke, et al.
Lancet (London, England)
|
February 12, 1983
Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial
J J Belch, A McKay, B McArdle, et al.
Thrombosis and Haemostasis
|
June 30, 1981
Successful treatment of Raynaud's Syndrome with prostacyclin
J J Belch, P Newman, J K Drury, et al.
British Journal of Rheumatology
|
October 23, 1998
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study
C M Black, L Halkier-Sørensen, J J Belch, et al.
Thrombosis and Haemostasis
|
April 30, 1982
DDAVP stimulates prostacyclin production
J J Belch, M Small, F McKenzie, et al.
Thrombosis and Haemostasis
|
February 28, 1984
A comparative study using immunological and biological assay of the haemostatic responses to DDAVP infusion venous occlusion and exercise in normal men
C V Prowse, A Farrugia, F E Boulton, et al.
Circulation
|
May 6, 1997
Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with intermittent claudication
J J Belch, P R Bell, D Creissen, et al.
Diabetologia
|
May 1, 1980
Blood viscosity in young male diabetics with and without retinopathy
G D Lowe, J M Lowe, M M Drummond, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 181) with videos related to
Sort By:
Page
of 19
Thrombosis Research
|
January 1, 1982
Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgery
J J Belch, D R Meek, G D Lowe, et al.
British Journal of Clinical Pharmacology
|
January 1, 1983
Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial
J J Belch, J Cormie, P Newman, et al.
Annals of the Rheumatic Diseases
|
March 1, 1995
Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study
J J Belch, H A Capell, E D Cooke, et al.
Lancet (London, England)
|
February 12, 1983
Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial
J J Belch, A McKay, B McArdle, et al.
Thrombosis and Haemostasis
|
June 30, 1981
Successful treatment of Raynaud's Syndrome with prostacyclin
J J Belch, P Newman, J K Drury, et al.
British Journal of Rheumatology
|
October 23, 1998
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study
C M Black, L Halkier-Sørensen, J J Belch, et al.
Thrombosis and Haemostasis
|
April 30, 1982
DDAVP stimulates prostacyclin production
J J Belch, M Small, F McKenzie, et al.
Thrombosis and Haemostasis
|
February 28, 1984
A comparative study using immunological and biological assay of the haemostatic responses to DDAVP infusion venous occlusion and exercise in normal men
C V Prowse, A Farrugia, F E Boulton, et al.
Circulation
|
May 6, 1997
Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with intermittent claudication
J J Belch, P R Bell, D Creissen, et al.
Diabetologia
|
May 1, 1980
Blood viscosity in young male diabetics with and without retinopathy
G D Lowe, J M Lowe, M M Drummond, et al.
Page
of 19